High Tower Advisors, LLC Aquestive Therapeutics, Inc. Transaction History
High Tower Advisors, LLC
- $76.8 Billion
- Q2 2025
A detailed history of High Tower Advisors, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 99,613 shares of AQST stock, worth $376,537. This represents 0.0% of its overall portfolio holdings.
Number of Shares
99,613
Previous 108,663
8.33%
Holding current value
$376,537
Previous $315,000
4.44%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AQST
# of Institutions
126Shares Held
47.6MCall Options Held
64.2KPut Options Held
204K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$37.1 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$20.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$16.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.98MShares$11.3 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.19MShares$8.28 Million0.32% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $202M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...